Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share ...

PolyPid Ltd. (NASDAQ: PYPD) Q4 2025 Earnings Call Transcript February 11, 2026 PolyPid Ltd. misses on earnings expectations.

A recent study published in the Journal of Sleep Research suggests that evening screen use might not be as physically stimulating for teenagers as many parents and experts have assumed. The findings ...

There's been a seismic shift in science, with scientists developing new AI tools and applying AI to just about any question that can be asked. Researchers are now putting actual seismic waves to work, ...

This report brings new evidence on how human capital is formed, showing that homes, neighborhoods, and workplaces play a ...